AI assistant
Sending…
Cartesian Therapeutics, Inc. — Director's Dealing 2019
Jul 25, 2019
33483_dirs_2019-07-25_f1a56b1e-6bc4-4620-8b1e-8cfded8c753a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2019-07-23
Reporting Person: Johnston Lloyd P. (COO and SVP, R&D)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-23 | Common Stock | M | 10000 | $0.47 | Acquired | 11606 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-07-23 | Employee Stock Option (right to buy) | $0.47 | M | 10000 | Disposed | 2019-07-23 | Common Stock (10000.0) | Direct |
Footnotes
F1: All shares underlying this option are fully vested.
More from Cartesian Therapeutics, Inc.
Regulatory Filings
2026
May 26
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 28
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Feb 5
Regulatory Filings
2026
Jan 9
Director's Dealing
2026
Jan 8
Director's Dealing
2026
Jan 8